CSF1R and neoplasm: Targeting colony-stimulating factor 1 receptor (CSF1R) or its ligand CSF-1 could prevent myeloid cell differentiation into MDSC and impede tumor progression (Cannarile et al., 2017; Yeung et al., 2021).